Affordable Quality Care for CKD patients

Quito-Ecuador, +593997331641, ventas@quantum.med.ec

Hemodialysis Innovation

Quantum Medical North America, Inc. is committed to bringing high-quality hemodiafiltration treatment to underserved communities.
Chronic kidney disease (CKD) is a progressive condition that affects >10% of the general population worldwide, amounting to >800 million individuals.

Hemodiafiltration is a major advancement in hemodialysis, but financial and technical barriers limit its use. Quantum Medical has developed an adaptation to enable hemodiafiltration by retrofitting standard dialysis machines.

Caring for CKD patients

THE QUANTUM CONVERSION SYSTEM

We retrofit conventional hemodialysis machines to perform hemodiafiltration (HDF). Hemodiafiltration has been shown to offer significant advantages over standard hemodialysis, including multiple clinical benefits and improved overall survival rates for chronic kidney disease patients

.

Market Potential

-There are more than 1 million conventional dialysis machines around the world.

-80% of dialysis worldwide, happen in India and China.

-In the USA, there are about 500 independent clinics, with an average of 10 conventional dialysis machines per clinic.

Priority Markets: LIMCs, China, India and United States

The Quantum Conversion System (QCS) is a competite solution compared to Hemodiafiltration machines

QCSHemodiafiltration Machine
It adapts to existing harwareRequieres clinics to change hardware
It uses existing suppliesIt requieres changes in the supply provision chain

Team

Dr. Irene Torres-CEO
A well known researcher with great experience in health and education studies. (https://orcid.org/0000-0002-0516-3090)

Bernardo CaƱizares-COO
A social entrepeneur, who has managed projects and institutions in Ecuador, Colombia, Denmark and the Netherlands.